Page last updated: 2024-11-08

2,4-dinitrophenylacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4-dinitrophenylacetic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID221513
CHEMBL ID1741495
SCHEMBL ID865986
MeSH IDM0087824

Synonyms (38)

Synonym
BB 0218608
benzeneacetic acid,4-dinitro-
nsc6225 ,
2,4-dinitrophenylacetic acid
acetic acid,4-dinitrophenyl)-
nsc-6225
643-43-6
NCI60_006597
benzeneacetic acid, 2,4-dinitro-
(2,4-bis(hydroxy(oxido)amino)phenyl)acetic acid
NCGC00013068
STK366374
2,4-dinitrophenylacetic acid, 95%
NCI6225
NCISTRUC1_000234
NCISTRUC2_000110
NCGC00096192-01
D1768
AKOS000119940
A837723
2-(2,4-dinitrophenyl)ethanoic acid
2-(2,4-dinitrophenyl)acetic acid
CCG-38136
NCGC00013068-02
FT-0610201
AKOS015893972
BBL023577
SCHEMBL865986
(2,4-dinitro-phenyl)-acetic acid
2,4-dimtrophenylacetic acid
KCNISYPADDTFDO-UHFFFAOYSA-N
CHEMBL1741495
mfcd00007227
DTXSID20862349
AS-49996
Q63409241
AMY25096
O10452
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.91 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]